Skip to Main Content
Announcement

Yale Cancer Center Experts to Share Latest Findings at 2026 AACR Conference

Oncology experts to present latest discoveries and research

2 Minute Read

Yale Cancer Center (YCC) experts are presenting research at the 2026 American Association for Cancer Research (AACR) Annual Meeting, April 17-22 at the San Diego Convention Center.

The meeting is one of the largest gatherings of cancer researchers and clinicians. Yale Cancer Center experts will share findings on patient-centered trials, new methods in pathology, and targeted treatments for head and neck cancers. A poster presentation is titled Humans cannot live by artificial intelligence (AI) alone.

Partial Schedule:

Advancing Patient-Centered Clinical Trials: Bringing Trials to Patients and Patients to Trials

Moderator: Roy Herbst, MD, PhD

Speaker: Pat LoRusso, DO

Humans cannot live by artificial intelligence (AI) alone

Presenting Authors: Kim Blenman, Ondrej Blaha, Sherry Qiu, Kelly Chen, Kiera Spall, Yiran Liu, Madison Williams, Marissa Villa, Valeri Vankov, Kwabena Oteng Agyapong, Di Li, Holly Rushmeier.

Epistasis and Evolution: How Genetic Interactions Shape Cancer Trajectories

Chair and Presenter: Jeffrey Peter Townsend, PhD


Cutting Edge Advances in Hematology

Session Chair: Rong Fan, PhD


A novel statistical framework for surrogate endpoint prediction of survival in neoadjuvant breast cancer trials

Presenting Author: Lajos Pusztai, MD

Pathologist’s perspective. Quantitative and reproducible assessment of ADC targets: Moving beyond conventional pathology

Presenter: David Rimm, MD, PhD

Phase 1 first-in-human multicenter open-label study of ZW191, a folate receptor targeting antibody-drug conjugate (ADC) in patients with advanced solid tumors.

Presenter: Pat LoRusso, DO


Immune-Genomic Mechanisms and Treatment of Peritoneal Metastases

Presenter: Raghav Sundar, MD, PhD


Advancing Precision Approaches to Head and Neck Cancers

Chair and Presenter: Barbara Burtness, MD


For journalists interested in arranging interviews, please contact lisa.carberg@yale.edu. For a full list of Yale Cancer Center’s upcoming presentations and posters at AACR, visit the conference website.

Article outro

About Yale Cancer Center

Yale Cancer Center, a National Cancer Institute (NCI) designated comprehensive cancer center since 1974, is recognized for its groundbreaking research and innovative cancer treatment approaches. As the only NCI-designated comprehensive cancer center in Connecticut, YCC is dedicated to excellence in patient care, research, and education. Through its partnership with Smilow Cancer Hospital, YCC continues to advance cancer research and offer hope to patients worldwide. Scientists and physicians at Yale School of Medicine and Smilow Cancer Hospital collaborate to provide effective approaches for prevention, detection, diagnosis, and treatment of cancer.

Media Contact

For media inquiries, please contact us.

Explore More

Featured in this article